SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers
Table 1
Characteristics of symptomatic patients on maintenance hemodialysis (N = 45) diagnosed as infected with SARS-CoV-2 from March to April of the epidemic and who were still alive 6 months later.
Variables
Total patients, N = 45 (%)
Values median [IQR1]
Age (years), median [IQR]
45 (100)
67.0 [59.0; 77.0]
Sex
Women
18 (40)
Men
27 (60)
Oxygen supply
Yes
22 (50)
No
22 (50)
Chest scan
39 (87)
No pulmonary injury
5 (11)
Minimal pulmonary injury (<10%)
7 (16)
Moderate pulmonary injury (10–25%)
14 (31)
Extensive to critical pulmonary injury (>25%)
13 (29)
Biological parameters
Lymphocyte nadir (1000–4800/mm3), median [IQR]
45 (100)
840.0 [642.0; 1274.0]
Ferritin peak (30–400 ng/mL), median [IQR]
34 (76)
409.0 [233.2; 860.2]
D-dimer peak (<500 ng/mL), median [IQR]
22 (49)
1276.0 [708.0; 1964.2]
CRP peak (<5 mg/L), median [IQR]
44 (98)
85.0 [14.8; 178.5]
BNP (100–400 pg/mL), median [IQR]
35 (78)
534.0 [286.5; 1570.5]
Troponin (<34.2 ng/mL), median [IQR]
38 (84)
38.8 [20.8; 72.0]
Neutrophil/lymphocyte ratio (<5), median [IQR]
43 (96)
5.0 [2.8; 13.2]
1IQR: interquartile range. Pulmonary extension was usually classified by five degrees of severity according to the French Society of Thoracic Imaging recommendations by grading lung involvement as absent or minimal (<10%), moderate (<25%), extensive (25–50%), severe (50–75%), and critical (>75%) (8). Because of the low number of hemodialysis patients with severe pulmonary injuries, extensive, severe, and critical involvement were gathered into one (>25%). Normal values.
